Certified by Founder Lodge
SANTÉ
United States - Austin, Texas
INVESTOR
1 Disclosed Funding Rounds $6,000,000
126 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Santé invests at the leading edge of innovation in Healthcare and Technology. We manage over a half-billion dollars of capital invested in two separate strategies.
Santé Ventures invests
| Company | Date | Round | Raised |
|---|---|---|---|
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Surgical Safety Technologies Inc. |
May, 10 ,2023 | Series A | $15,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Surgical Safety Technologies Inc. |
May, 10 ,2023 | Series A | $15,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Solu Therapeutics |
August, 01 ,2023 | Seed | $31,000,000 |
Surgical Safety Technologies Inc. |
May, 10 ,2023 | Series A | $15,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Wave |
March, 08 ,2023 | Seed | $6,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Solu Therapeutics |
August, 01 ,2023 | Seed | $31,000,000 |
Solu Therapeutics |
August, 01 ,2023 | Seed | $31,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
Surgical Safety Technologies Inc. |
May, 10 ,2023 | Series A | $15,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
Solu Therapeutics |
August, 01 ,2023 | Seed | $31,000,000 |
Surgical Safety Technologies Inc. |
May, 10 ,2023 | Series A | $15,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Wave |
March, 08 ,2023 | Seed | $6,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
Solu Therapeutics |
August, 01 ,2023 | Seed | $31,000,000 |
Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Solu Therapeutics |
August, 01 ,2023 | Seed | $31,000,000 |
Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
Surgical Safety Technologies Inc. |
May, 10 ,2023 | Series A | $15,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
Solu Therapeutics |
August, 01 ,2023 | Seed | $31,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
Surgical Safety Technologies Inc. |
May, 10 ,2023 | Series A | $15,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Clairity, Inc. |
November, 14 ,2025 | Series B | $43,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
AI Proteins |
November, 21 ,2025 | Series A | $41,500,000 |
Solu Therapeutics |
August, 01 ,2023 | Seed | $31,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Clairity, Inc. |
November, 14 ,2025 | Series B | $43,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
Clairity, Inc. |
November, 14 ,2025 | Series B | $43,000,000 |
Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
AI Proteins |
November, 21 ,2025 | Series A | $41,500,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
AI Proteins |
November, 21 ,2025 | Series A | $41,500,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
Graici |
February, 04 ,2026 | Series A | $7,500,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
Clairity, Inc. |
November, 14 ,2025 | Series B | $43,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Clairity, Inc. |
November, 14 ,2025 | Series B | $43,000,000 |
Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
AI Proteins |
November, 21 ,2025 | Series A | $41,500,000 |
AI Proteins |
November, 21 ,2025 | Series A | $41,500,000 |
Graici |
February, 04 ,2026 | Series A | $7,500,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
beHuman Corp. |
February, 05 ,2026 | Seed | $4,000,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
Clairity, Inc. |
November, 14 ,2025 | Series B | $43,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Clairity, Inc. |
November, 14 ,2025 | Series B | $43,000,000 |
AI Proteins |
November, 21 ,2025 | Series A | $41,500,000 |
AI Proteins |
November, 21 ,2025 | Series A | $41,500,000 |
Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
Graici |
February, 04 ,2026 | Series A | $7,500,000 |
ABK Biomedical Inc. |
October, 15 ,2025 | Series D | $35,000,000 |
OutcomesAI |
October, 16 ,2025 | Seed | $10,000,000 |
Clairity, Inc. |
November, 14 ,2025 | Series B | $43,000,000 |
AI Proteins |
November, 21 ,2025 | Series A | $41,500,000 |
Graici |
February, 04 ,2026 | Series A | $7,500,000 |
beHuman Corp. |
February, 05 ,2026 | Seed | $4,000,000 |
E2 - Endovascular Engineering |
April, 09 ,2026 | Series C | $80,000,000 |
Axon Therapies Inc.
Surgical Safety Technologies Inc.
Solu Therapeutics
Apreo Health
Reprieve Cardiovascular
Endogenex
Wave
ABK Biomedical Inc.
OutcomesAI
Clairity, Inc.
AI Proteins
Graici
beHuman Corp.
E2 - Endovascular Engineering
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CREAO AI | $10,000,000 | (Apr 21, 2026)
TraqCheck | $8,000,000 | (Apr 21, 2026)
Antioch | $8,500,000 | (Apr 21, 2026)
ScreenPoint Medical | $14,000,000 | (Apr 21, 2026)
Ultralight | $9,300,000 | (Apr 21, 2026)